MedKoo Cat#: 596402 | Name: Medazomide

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Medazomide is an antispasmodic drug.

Chemical Structure

Medazomide
Medazomide
CAS#300-22-1

Theoretical Analysis

MedKoo Cat#: 596402

Name: Medazomide

CAS#: 300-22-1

Chemical Formula: C6H9N3O2

Exact Mass: 155.0695

Molecular Weight: 155.15

Elemental Analysis: C, 46.45; H, 5.85; N, 27.08; O, 20.62

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Medazomide; Medazomidum; L-1777; L 1777; L1777;
IUPAC/Chemical Name
1-methyl-6-oxo-1,4,5,6-tetrahydropyridazine-3-carboxamide
InChi Key
LXFKHPXXAPOYCC-UHFFFAOYSA-N
InChi Code
InChI=1S/C6H9N3O2/c1-9-5(10)3-2-4(8-9)6(7)11/h2-3H2,1H3,(H2,7,11)
SMILES Code
O=C(C(CC1)=NN(C)C1=O)N
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 155.15 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Lee JS, Wu R, Wong T, DuBois SG, Matthay K, Gustafson C, Hawkins R, Roy-Burman A. Extended Sedation With Continuous Midazolam or Dexmedetomidine Infusion for Young Children Receiving 131 I-MIBG Radiopharmaceutical Therapy for Advanced Neuroblastoma. Pediatr Blood Cancer. 2016 Mar;63(3):471-8. doi: 10.1002/pbc.25827. Epub 2015 Nov 19. PubMed PMID: 26585842. 2: Wutzler A, Mueller A, Loehr L, Huemer M, Parwani AS, Attanasio P, Blaschke F, Storm C, Boldt LH, Haverkamp W. Minimal and deep sedation during ablation of ventricular tachycardia. Int J Cardiol. 2014 Mar 1;172(1):161-4. doi: 10.1016/j.ijcard.2013.12.175. Epub 2014 Jan 8. PubMed PMID: 24447761. 3: Nosál'ová G, Strapková A, Korpás J. [Action of medazonamid on cough in an experiment]. Farmakol Toksikol. 1986 Jan-Feb;49(1):81-4. Russian. PubMed PMID: 3948994. 4: NICOLIS FB, PASQUARIELLO G. [Controlled clinical experiments with new antitussive drugs. I. Methodological considerations and evaluation of the antitussive activity of medazonamide]. Clin Ter. 1962 Aug 15;23:215-25. Italian. PubMed PMID: 13938444.